G. Mloston et al. / Journal of Fluorine Chemistry 131 (2010) 578–583
581
2
C13H20F3NO2 (279.31): C, 55.90; H, 7.56; N, 5.01. Found: C, 55.95;
H, 7.85; N, 5.01.
(1H, q, JH,H = 6.7 Hz, CH3CH), 6.52 (1H, s, OH), 7.26–7.51 (5H, m,
C6H5). 13C NMR (50 MHz, CDCl3):
d 9.5, 19.2, 19.6 (3CH3), 20.9
(Z)-N-Isopropyl-[(1R,2S)-2-(trifluoromethyl)bornan-2-ol-3-
yliden]amine N-oxide (5c). The crude product was purified by
column chromatography on silica gel using first CH2Cl2/hexane
(2:1) and then CH2Cl2 with increasing amounts of ethyl acetate
(0–5%) as eluents. The product was isolated as a yellowish oil. An
(CH3CH), 22.7, 28.7 (2CH2), 51.1 (CH), 50.7, 53.0 (2Cq), 69.0
(CH3CH), 81.5 (q, 2JC-F = 28.8 Hz, Cq), 125.1 (q, 1JC,F = 290.0 Hz, CF3),
126.9, 128.5, 128.6 (5CH arom.), 137.8 (Cq arom.), 151.6 (C55N). 19
F
NMR (188 MHz, CDCl3):
d
ꢀ66.6 (s, CF3). IR (KBr):
v
3600ꢀ3100w
(br, OH), 3014m, 2989m, 2957m, 2891w, 1771w, 1595m, 1495m,
1457m, 1441w, 1424w, 1399w, 1295m, 1263s, 1233m, 1174s,
1162s, 1149vs, 1127w, 1114s, 1056m, 1012m, 982m, 957m, 923w,
866w, 835w, 765w, 736m, 720m, 705m, 641m cmꢀ1. EI-MS m/z (rel.
int.): 355 (0.8, M+), 338 (0.3), 251 (0.7), 234 (0.6), 218 (0.4), 136
(1.3), 106 (10), 105 (100), 104 (4), 103 (5), 79 (6), 77 (6). HR-EI-MS:
Calcd for C19H24F3NO2: 355.1759; found: 355.1758.
analytically pure sample was obtained by crystallisation. Yield:
25
260 mg (82%). Colourless crystals, m.p. 40–43 8C (hexane); [
a]
D
+158.2 (c 0.2, CHCl3). 1H NMR (200 MHz, CDCl3):
d
1.00, 1.10, 1.14
(9H, 3s, 3CH3), 1.37–1.45 (6H, m, (CH3)2CH), 1.58–2.03 (4H, m,
3
2CH2), 2.75 (1H, d, JH,H = 4.5 Hz, CH), 4.27–4.40 (1H, m,
(CH3)2CHN), 6.68 (1H, s, OH). 13C NMR (50 MHz, CDCl3):
d 9.6,
19.1, 20.0 (3CH3), 19.4 (CH2), 21.6, 22.9 ((CH3)2CH), 28.8 (CH2),
50.7, 53.0 (2Cq), 51.5 (CH), 60.7 ((CH3)2CH), 81.6 (q, 2JC,F = 28.6 Hz,
Cq), 125.2 (q, 1JC,F = 28.6 Hz, CF3), 150.9 (C55N). 19F NMR (188 MHz,
(Z)-N-Phenyl-[(1R,2S)-2-(trifluoromethyl)bornan-2-ol-3-yliden]-
amine N-oxide (5g). The pure product was obtained by crystal-
lisation. Yield: 300 mg (90%). Colourless crystals, m.p. 160–163 8C
CDCl3):
d
ꢀ66.8 (s, CF3). IR (KBr):
v
3432m (br, OH), 2981m, 2941m,
(CH2Cl2/hexane);
(200 MHz, CDCl3):
[a
]
D
+58.78 (c 0.010, CHCl3). 1H NMR
25
2883w, 1611m (C55N), 1497w, 1455m, 1395m, 1378m, 1296m,
1261s, 1203s, 1183s, 1157vs, 1112s, 1076m, 1015m, 994w, 961m,
927w, 868w, 834w, 738m, 645m cmꢀ1. CI-MS (NH3) m/z (rel. int.):
294 (100, [M+1]+), 278 (30), 276 (14). HR-ESI-MS (NaI): Calcd for
d 0.87, 1.10, 1.12 (9H, 3s, 3CH3), 1.62–1.95
(4H, m, 2CH2), 2.42 (1H, d, JH,H = 4.2 Hz, CH), 6.93 (1H, s, OH),
7.42–7.48 (5H, m, C6H5). 13C NMR (50 MHz, CDCl3):
9.5, 19.2, 21.1
2
d
(3CH3), 22.7, 28.7 (2CH2), 51.2, 53.2 (2Cq), 53.3 (CH), 81.5 (q,
1
C14H22F3NO2Na: 316.1500; found: 316.1504.
2JC,F = 29.0 Hz, Cq), 125.0 (q, JC,F = 289.9 Hz, CF3), 122.9, 129.2,
(Z)-N-tert-Butyl-[(1R,2S)-2-(trifluoromethyl)bornan-2-ol-3-yli-
130.2 (5CH arom.), 145.2 (Cq arom.), 154.7 (C55N). 19F NMR
den]amine N-oxide (5d). The crude product was purified by column
chromatography on silica gel using first a mixture of CH2Cl2/
hexane (2:1) and then CH2Cl2 with increasing amounts of ethyl
acetate (0–5%) as eluents. The product was isolated as a yellowish
oil. An analytically pure sample was obtained by crystallisation.
Yield: 290 mg (94%). Colourless crystals, m.p. 54–58 8C (hexane);
(188 MHz, CDCl3):
d
ꢀ67.0 (s, CF3). IR (KBr):
v
3600ꢀ2880w (br,
OH), 106w, 3077w, 3018m, 3002s, 2989m, 2977s, 2944m, 2926m,
2881w, 1887w, 1806w, 1606m, 1584m, 1489s, 1459m, 1401m,
1382m, 1320m, 1287s, 1267vs, 1233m, 1198vs, 1179s, 1164vs,
1150vs, 1117s, 1107s, 1073m, 1010m, 979m, 953m, 919m, 866w,
830w, 773s, 739m, 720m, 692s, 637m cmꢀ1. EI-MS m/z (rel. int.):
327 (63, M+), 311 (22), 310 (38), 244 (72), 228 (13), 213 (22), 212
(18), 202 (12), 200 (18), 158 (10), 130 (100), 104 (65), 91 (27), 77
(59). Anal. Calcd for C17H20F3NO2 (327.35): C, 62.38; H, 6.16; N,
4.28. Found: C, 62.52; H, 5.89; N, 4.25.
[a
]
D
25 +154.5 (c 0.2, CHCl3). 1H NMR (300 MHz, CDCl3):
d
0.97, 1.07,
1.13 (9H, 3s, 3CH3), 1.55 (9H, s, (CH3)3C), 1.55–2.00 (4H, m, 2CH2),
3
3.06 (1H, d, JH,H = 4.8 Hz, CH). 13C NMR (75.5 MHz, CDCl3):
d 9.6,
19.5, 21.8 (3CH3), 22.7 (CH2), 28.2 ((CH3)3C), 28.6 (CH2), 50.9, 52.0
(2Cq), 52.2 (CH), 71.0 ((CH3)3CN), 83.2 (q, 2JC,F = 28.8 Hz, Cq), 125.3
(Z)-N-(4-Methoxyphenyl)-[(1R,2S)-2-(trifluoromethyl)bornan-2-
ol-3-yliden]amine N-oxide (5h). The pure product was obtained by
(q, 1JC,F = 290.0 Hz, CF3), 151.0 (C55N). 19F NMR (188 MHz, CDCl3):
d
ꢀ66.2 (s, CF3). IR (KBr):
v
3448m (br, OH), 2985m, 2942m, 2884w,
crystallisation. Yield: 320 mg (90%). Colourless crystals, m.p. 164–
+69.50 (c 0.012, CHCl3). 1H NMR
25
1582w, 1459w, 1395w, 1372w, 1293w, 1274w, 1257m, 1229m,
1200m, 1186m, 1164vs, 1151vs, 1125s, 1110s, 1008w, 983w, 960w,
833w, 731w, 656w cmꢀ1. CI-MS (NH3) m/z (rel. int.): 309 (17), 308
(100, [M+1]+), 252 (89). Anal. Calcd for C15H24F3NO2 (307.36): C,
58.62; H, 7.77. Found: C, 58.27; H, 7.72.
167 8C (CH2Cl2/hexane); [
(200 MHz, CDCl3):
2CH2), 2.45 (1H, d, 2JH,H = 4.0 Hz, CH), 3.81 (3H, s, CH3O), 7.05 (1H,
s, OH), 6.89–7.36 (4H, m, C6H4). 13C NMR (50 MHz, CDCl3):
9.5,
a
]
D
d
0.86, 1.08 (6H, 3s, 3CH3), 1.68–2.00 (4H, m,
d
19.2, 21.0 (3CH3), 22.7, 28.7 (2CH2), 51.2, 53.0 (2Cq), 53.5 (CH), 55.4
(CH3O), 81.50 (q, 2JC,F = 29.0 Hz, Cq), 125.1 (q, 1JC,F = 289.8 Hz, CF3),
114.1, 124.2 (4CH arom.), 138.4, 154.0 (2Cq arom.), 160.7 (C55N).
(Z)-N-Cyclohexyl-[(1R,2S)-2-(trifluoromethyl)bornan-2-ol-3-yli-
den]amine N-oxide (5e). The crude product was purified by column
chromatography on silica gel using CH2Cl2/hexane (2:1) and then
CH2Cl2 with increasing amounts of ethyl acetate (0–5%) as eluents.
The product was isolated as a yellowish oil. An analytically pure
sample was obtained by crystallisation. Yield: 310 mg (93%).
Colourless crystals, m.p. 74–76 8C (hexane); [
CHCl3). 1H NMR (300 MHz, CDCl3):
19F NMR (188 MHz, CDCl3):
d
ꢀ68.1 (s, CF3). IR (KBr):
v
3600ꢀ3450w (br, OH), 3119w, 3001w, 2987w, 2941w, 2846w,
1611w, 1599m, 1507s, 1459w, 1323w, 1285w, 1258s, 1198m,
1168vs, 1146s, 1110s, 1024w, 1009w, 977w, 954w, 917w, 845m,
812w, 732w, 608w cmꢀ1. EI-MS m/z (rel. int.): 357 (56, M+), 341
(41), 340 (25), 274 (32), 258 (11), 257 (23), 243 (11), 242 (17), 230
(21), 188 (18), 161 (11), 160 (70), 135 (11), 134 (100), 124 (33), 123
(24), 122 (11), 120 (47), 109 (18), 108 (12), 107 (17), 95 (26), 92
(14), 77 (25). HR-EI-MS: Calcd for C18H22F3NO2: 357.1552; found:
357.1554. Anal. Calcd for C18H22F3NO2 (357.38): C, 60.49; H, 6.21;
N, 3.92. Found: C, 60.41; H, 5.83; N, 3.90.
25
a]
D
+168.0 (c 0.2,
d
0.98, 1.08, 1.12 (9H, 3s, 3CH3),
3
1.15–1.40 (3H, m), 1.52–2.15 (11H, m), 2.72 (1H, d, JH,H = 4.7 Hz,
CH), 3.84–3.98 (1H, m, CHN), 6.71 (1H, OH). 13C NMR (75.5 MHz,
CDCl3):
d 9.6, 19.4, 21.6 (3CH3), 23.0, 24.7, 28.8, 28.9, 29.9 (7CH2),
50.6, 53.0 (2Cq), 51.4 (CH), 68.6 (CHN), 83.9 (q, 2JC,F = 28.6 Hz, Cq),
125.2 (q, JC,F = 290.0 Hz, CF3), 150.9 (C55N). 19F NMR (188 MHz,
1
CDCl3):
d
ꢀ67.9 (s, CF3). IR (KBr):
v
3432m (br, OH), 2997m, 2938vs,
(Z)-N-Methyl-[(1R,2S)-2-(trifluoromethyl)-2-(trimethylsilyloxy)-
bornan-3-yliden]amine N-oxide (6). The crude product was purified
by column chromatography on silica gel using first CH2Cl2/hexane
(3:2) and then CH2Cl2 with increasing amounts of ethyl acetate (0–
50%) as eluents. The product was isolated as a yellowish oil. Yield:
2866m, 1607m (C55N), 1496w, 1461s, 1395m, 1372w, 1296s,
1260vs, 1170vs, 1156vs, 1189s, 1111vs, 1024w, 1005w, 962s, 928w,
836w, 739w, 652m cmꢀ1. CI-(NH3) m/z (rel. int.): 335 (19), 334
(100, [M+1]+), 316 (11). Anal. Calcd for C17H26F3NO2 (333.39): C,
61.24; H, 7.86. Found: C, 61.25; H, 7.86.
270 mg (80%). An analytically pure sample was obtained by
25
(Z)-N-[(10R)-10-Phenylethyl]-[(1R,2S)-2-(trifluoromethyl)bornan-
crystallisation. Colourless crystals, m.p. 74–76 8C (hexane); [
+133.2 (c 0.008, CHCl3). 1H NMR (300 MHz, CDCl3):
a]
D
2-ol-3-yliden]amine N-oxide (5f). The pure product was obtained by
d
0.18 (9H, s,
crystallisation. Yield: 290 mg (81%). Colourless crystals, m.p. 124–
(CH3)3Si), 0.93, 1.01, 1.09 (9H, 3s, 3CH3), 1.40–2.00 (4H, m, 2CH2),
+131.5 (c 0.010, CHCl3). 1H NMR (200 MHz,
2.60 (1H, JH,H = 4.4 Hz, CH), 3.68 (3H, s, CH3N). 13C NMR
25
3
125 8C (Et2O); [
CDCl3):
1.77 (3H, d, 2JH,H = 6.7 Hz, CH3), 2.82 (1H, d, 2JH,H = 4.4 Hz, CH), 5.21
a
]
D
d
0.61, 0.85, 1.00 (9H, 3s, 3CH3), 1.52–1.97 (4H, m, 2CH2),
(75.5 MHz, CDCl3):
d 1.9 ((CH3)3Si), 10.7, 19.6, 21.9 (3CH3), 23.8,
27.9 (2CH2), 48.8, 55.9 (2Cq), 52.6 (CH), 81.4 (q, 2JC,F = 29.3 Hz, Cq),